USD 16.4 billion
Immunoglobulin Market Size, Share, and Growth Analysis
Immunoglobulin Market By Product Type (IgG, IgA), By Form (Liquid, Lyophilized), By Mode of Delivery, By Application, By Distribution Channel, By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35G2149 |
Region:
Global |
Published Date: March, 2025
Pages:
219
|Tables:
64
|Figures:
75
Format -
Immunoglobulin Market Insights
Global Immunoglobulin Market size was valued at USD 14.97 billion in 2023 and is poised to grow from USD 16.08 billion in 2024 to USD 27.42 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).
The global Immunoglobulin market is experiencing significant growth driven by factors such as the increasing prevalence of immunological disorders, advancements in diagnosis and treatment, favorable regulatory environment, and rising healthcare expenditure.
Technological advancements and investments in research and development are enhancing the quality and efficacy of Immunoglobulin therapies. Expansion in emerging markets, particularly in Asia-Pacific and Latin America, presents lucrative opportunities for market players. These market insights indicate a positive growth trajectory for the global Immunoglobulin market, urging industry stakeholders to focus on innovation, capacity expansion, and market penetration strategies to meet the rising demand for Immunoglobulin therapies.
US Immunoglobulin Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
subcutaneous immunoglobulin (SCIG)
Fastest Growth
subcutaneous immunoglobulin (SCIG)
Growth Rate
6.8% CAGR
Global Immunoglobulin Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Immunoglobulin Market Segments Analysis
Global Immunoglobulin Market is segmented by Product Type, Form, Mode of Delivery, Application, Distribution Channel and region. Based on Product Type, the market is segmented into IgG, IgA, IgM, IgE and IgD. Based on Form, the market is segmented into Liquid and Lyophilized. Based on Mode of Delivery, the market is segmented into Intravenous, Subcutaneous and Intramuscular. Based on Application, the market is segmented into Primary Immunodeficiency Disease, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura (ITP), Guillain-Barre Syndrome and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Drug Stores & Retail Pharmacy and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Analysis by Product Type
The two main sub-segments within this segment are intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG).
The dominant sub-segment within the product type segment is currently intravenous immunoglobulin (IVIG). IVIG has been widely used for many years and has established a strong market presence. It is preferred in cases where rapid increase in antibody levels is required, such as acute infections or critical medical conditions.
The fastest growing sub-segment within the product type segment is subcutaneous immunoglobulin (SCIG). SCIG offers several advantages, including convenience, fewer side effects, and the ability for patients to self-administer at home. The growing preference for home-based care, increasing awareness of SCIG benefits, and technological advancements in delivery systems contribute to the rapid growth of the SCIG sub-segment. Additionally, the ongoing development of novel SCIG products and improved patient education further drive its adoption and market growth.
Analysis by Application
The main sub-segments within the application segment include primary immunodeficiency diseases, autoimmune disorders, infectious diseases, hypogammaglobulinemia, neurological disorders, and others.
The dominant sub-segment within the application segment of the Immunoglobulin market is primary immunodeficiency diseases. The increasing prevalence of primary immunodeficiencies, coupled with the growing awareness and diagnosis of these conditions, drives the demand for Immunoglobulin therapy to bolster the immune system in affected individuals.
The fastest growing sub-segment within the application segment is neurological disorders. The utilization of Immunoglobulin therapy for treating neurological conditions like CIDP, GBS, and myasthenia gravis has gained recognition and acceptance. The growing incidence of these disorders and the effectiveness of Immunoglobulin therapy in managing them contribute to the rapid growth of this sub-segment. Moreover, ongoing research and development activities in the field of neurological disorders further drive the market growth.
Global Immunoglobulin Market By type
To get detailed analysis on other segments, Request For Free Sample Report
Immunoglobulin Market Regional Insights
One dominant region in the global Immunoglobulin market is North America. North America holds a significant share in the market due to several factors. The region has a well-established healthcare infrastructure, advanced research facilities, and a high prevalence of autoimmune and immunodeficiency disorders. Additionally, favorable reimbursement policies and government initiatives to promote immunization and healthcare access further contribute to the dominance of North America in the Immunoglobulin market. The presence of major pharmaceutical companies and biotech firms in the region also plays a crucial role in driving market growth.
One of the fastest growing regions in the global Immunoglobulin market is Asia-Pacific. The region is witnessing rapid growth in the market due to factors such as increasing healthcare expenditure, rising awareness about immunodeficiency disorders, and a large patient population. Countries like China and India have a significant demand for Immunoglobulin products, driven by the growing prevalence of chronic diseases and an aging population. Furthermore, increasing investments in healthcare infrastructure, technological advancements, and government initiatives to improve healthcare access are propelling the growth of the Immunoglobulin market in the Asia-Pacific region.
Global Immunoglobulin Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Immunoglobulin Market Dynamics
Immunoglobulin Market Drivers
Increasing Prevalence of Immunological Disorders
- One key driver of the global Immunoglobulin market is the increasing prevalence of immunological disorders. Immunoglobulins are crucial in the treatment of various conditions, including primary immunodeficiency diseases, autoimmune disorders, and infectious diseases. The rising incidence of these disorders, coupled with improved diagnostic capabilities and awareness, has fuelled the demand for Immunoglobulin therapies. Factors such as genetic predisposition, environmental factors, and lifestyle changes contribute to the growing prevalence of immunological disorders globally. Additionally, advancements in healthcare infrastructure, increased access to healthcare services, and rising healthcare expenditure further support the market growth.
Immunoglobulin Market Restraints
High Cost of Immunoglobulin Therapies
- One significant restraint in the global Immunoglobulin market is the high cost of Immunoglobulin therapies. The production, purification, and storage of Immunoglobulins require complex and expensive manufacturing processes, leading to high production costs. This, in turn, affects the pricing of Immunoglobulin products, making them relatively expensive for patients and healthcare systems. The high cost poses a challenge, particularly in developing countries with limited healthcare budgets and affordability constraints. Moreover, reimbursement issues and insurance coverage limitations for Immunoglobulin therapies add to the financial burden on patients. Efforts to reduce the cost of production, increase market competition, and improve access to affordable Immunoglobulin therapies are essential to address this restraint and ensure broader patient access to these life-saving treatments.
Request Free Customization of this report to help us to meet your business objectives.
Immunoglobulin Market Competitive Landscape
The global Immunoglobulin market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Immunoglobulins. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions.
Top Players in Immunoglobulin Market
- Pfizer Inc
- CSL Limited
- Takeda Pharmaceutical Company Limited
- Grifols, S.A.
- Octapharma AG
- Baxter International
- Kedrion Biopharma
- Bio Products Laboratory Ltd. (BPL) Group
- ADMA Biologics Inc.
- China Biologic Products Holdings, Inc.
- Shanghai RAAS Blood Products Co., Ltd.
- Mankind Pharma Ltd.(Bharat Serums and Vaccines Ltd.)
- Green Cross Corporation
- LFB Group
- Emergent BioSolutions Inc.
- Japan Blood Products Organization (JBPO)
- China Grand Enterprises, Inc (Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.)
- Intas Pharmaceuticals Ltd.
- Kamada Ltd.
- Prothya Biosolutions B.V.
Recent Developments
- In February 2023, Kedrion Biopharma, a biopharmaceutical company specializing in plasma-derived products, announced the completion of a Phase 3 clinical trial for its novel subcutaneous immunoglobulin (SCIG) therapy, KEDRABIO. The trial demonstrated the safety and efficacy of KEDRABIO in patients with primary immunodeficiencies, offering a potential alternative treatment option.
Immunoglobulin Key Market Trends
- One key market trend in the global Immunoglobulin market is the increasing adoption of intravenous immunoglobulin (IVIG) therapy. IVIG therapy involves the administration of Immunoglobulin intravenously to patients with immunodeficiency disorders, autoimmune diseases, and certain neurological conditions. The demand for IVIG therapy is growing due to its effectiveness in treating various medical conditions and the expanding awareness of its benefits among healthcare providers and patients. Factors such as advancements in production methods, improved product safety, and expanded indications for IVIG therapy are driving its adoption. Additionally, the rising prevalence of immunological disorders and the growing geriatric population contribute to the increasing demand for Immunoglobulin products and IVIG therapy.
Immunoglobulin Market SkyQuest Analysis
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
The global Immunoglobulin market is experiencing significant growth driven by factors such as the increasing prevalence of immunological disorders, rising awareness about immunoglobulin therapy, and advancements in production and purification techniques. Immunoglobulins are widely used in the treatment of primary immunodeficiency diseases, autoimmune disorders, and certain neurological conditions. North America dominates the market due to a well-established healthcare infrastructure and high demand. Meanwhile, the Asia-Pacific region is emerging as a fast-growing market due to increasing healthcare expenditure, a large patient population, and improving healthcare infrastructure. Key players in the market are focusing on research and development activities to develop novel immunoglobulin therapies and expand their market presence.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 14.97 billion |
| Market size value in 2032 | USD 27.42 billion |
| Growth Rate | 6.9% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Immunoglobulin Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Immunoglobulin Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Immunoglobulin Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Immunoglobulin Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Immunoglobulin Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Immunoglobulin Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
